Literature DB >> 10703944

Inhibition of CDK2, CDK4 and cyclin E and increased expression of p27Kip1 during treatment with interferon-alpha in carcinoid tumor cells.

Y Zhou1, S Wang, A Gobl, K Oberg.   

Abstract

IFN-alpha has presented antitumor effect in about 50% of carcinoid tumor patients, though the antitumor mechanism of IFN-alpha is still to be elucidated. In this study we demonstrated that IFN-alpha could result in accumulation of S-phase population and upregulation of cyclin-dependent kinase inhibitor (CKI), p27. Moreover, IFN-alpha inhibits DNA synthesis assessed by [3H] thymidine incorporation and colony formation on soft agar. Immunodepletion of p27 increased CDK2- and cyclin E-associated kinase activities. These data suggest that IFN-alpha exerts its antiproliferative effects in the neuroendocrine differentiated cell lines by: 1) inhibition of DNA synthesis and colony formation, 2) upregulation on the mRNA and protein expressions of the CKI, p27.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10703944

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  4 in total

1.  FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.

Authors:  María Paula Ceballos; Juan Pablo Parody; Ariel Darío Quiroga; María Laura Casella; Daniel Eleazar Francés; María Cecilia Larocca; Cristina Ester Carnovale; María de Luján Alvarez; María Cristina Carrillo
Journal:  J Interferon Cytokine Res       Date:  2014-06-20       Impact factor: 2.607

2.  IRF6 in development and disease: a mediator of quiescence and differentiation.

Authors:  Caleb M Bailey; Mary J C Hendrix
Journal:  Cell Cycle       Date:  2008-04-29       Impact factor: 4.534

3.  Cyto-reduction of neuroendocrine tumours using Sandostatin LAR in combination with Infergen: results of a case series.

Authors:  Hank S Wang; David S Oh; Gordon V Ohning; Joseph R Pisegna
Journal:  J Pharm Pharmacol       Date:  2006-12       Impact factor: 3.765

4.  Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway.

Authors:  C Peng; W Zeng; J Su; Y Kuang; Y He; S Zhao; J Zhang; W Ma; A M Bode; Z Dong; X Chen
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.